Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Overview of attention for article published in The Lancet, January 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 80 news outlets
blogs: 9 blogs
policy: 1 policy source
twitter: 217 X users
patent: 1 patent

facebook: 10 Facebook pages
wikipedia: 2 Wikipedia pages
reddit: 6 Redditors
f1000: 1 research highlight platform
video: 1 YouTube creator

Citations

dimensions_citation: 671 Dimensions

Readers on

mendeley: 881 Mendeley
citeulike: 1 CiteULike

Summary News Blogs Policy documents X Patents Facebook Wikipedia Reddit Research highlights YouTube Dimensions citations

So far, Altmetric has seen 102 news stories from 80 outlets.

PBS extends cannabidiol indication to include Lennox-Gastaut syndrome

Thelimbic, 06 Jun 2023

The oral liquid cannabidiol Epidyolex is now available on the PBS for the treatment of seizures associated with Lennox-Gastaut…

CBD oil is having a moment. What's it for and what's behind all the hype?

Pressfrom, 23 Jan 2022

If you believed all the hype extolling its apparent virtues, CBD oil just might be the elixir of life.

News story from Western Australia Today on Saturday 22 January 2022

Western Australia Today, 22 Jan 2022

News story from The Age on Saturday 22 January 2022

The Age, 22 Jan 2022

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 98 additional news stories.